Market Cap (In CNY)
7.62 Billion
Revenue (In CNY)
1.87 Billion
Net Income (In CNY)
127.44 Million
Avg. Volume
3.21 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 17.94-48.39
- PE
- 37.27
- EPS
- 0.97
- Beta Value
- 0.583
- ISIN
- CNE1000051J4
- CUSIP
- -
- CIK
- -
- Shares
- 210960000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Baofu Zheng
- Employee Count
- -
- Website
- https://www.chemexpress.cn
- Ipo Date
- 2021-06-08
- Details
- Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
More Stocks
-
7246
-
0A55
-
145020Hugel, Inc.
145020
-
AMANAH
-
FRAGUAB
-
ACCO
-
WGO
-
SNGXSoligenix, Inc.
SNGX